-
1
-
-
0002090268
-
An analysis of prognostic factors in 8,500 patients with cutaneous melanoma
-
Balch CM, Houghton AN, Milton GW, et al., eds. Philadelphia: JB Lippincott & Williams
-
Balch CM, Soong SJ, Shaw HM, et al. An analysis of prognostic factors in 8,500 patients with cutaneous melanoma. In: Balch CM, Houghton AN, Milton GW, et al., eds. Cutaneous melanoma. 2nd ed. Philadelphia: JB Lippincott & Williams, 1992:165-187
-
(1992)
Cutaneous Melanoma. 2nd Ed.
, pp. 165-187
-
-
Balch, C.M.1
Soong, S.J.2
Shaw, H.M.3
-
2
-
-
0023811253
-
Lethal skin melanomas: Identifying patients at risk
-
Slingluff CL, Vollmer RT, Reintgen DS. Lethal skin melanomas: identifying patients at risk. Ann Surg 1988;208: 150-161
-
(1988)
Ann Surg
, vol.208
, pp. 150-161
-
-
Slingluff, C.L.1
Vollmer, R.T.2
Reintgen, D.S.3
-
3
-
-
0026010995
-
Molecular themes in oncogenesis
-
Bishop JM. Molecular themes in oncogenesis. Cell 1991; 64:235-248
-
(1991)
Cell
, vol.64
, pp. 235-248
-
-
Bishop, J.M.1
-
5
-
-
0024255007
-
Proto-oncogenes and prognosis in early carcinoma of the uterine cervix
-
Riou GF. Proto-oncogenes and prognosis in early carcinoma of the uterine cervix. Cancer Survey 1988;7:442-455
-
(1988)
Cancer Survey
, vol.7
, pp. 442-455
-
-
Riou, G.F.1
-
6
-
-
0024367963
-
Elevated expression of c-myc oncoprotein correlates with poor prognosis in head and neck squamous cell carcinoma
-
Field JK, Spandidos DA, Stell PM, et al. Elevated expression of c-myc oncoprotein correlates with poor prognosis in head and neck squamous cell carcinoma. Oncogene 1989;4:1463-1468
-
(1989)
Oncogene
, vol.4
, pp. 1463-1468
-
-
Field, J.K.1
Spandidos, D.A.2
Stell, P.M.3
-
7
-
-
12244259456
-
c-myc oncoprotein expression acts as a prognostic marker in high-risk malignant melanoma
-
Ross DA, Wilson GD. c-myc oncoprotein expression acts as a prognostic marker in high-risk malignant melanoma. B J Cancer 1994;69(XXI):55
-
(1994)
B J Cancer
, vol.69
, Issue.XXI
, pp. 55
-
-
Ross, D.A.1
Wilson, G.D.2
-
8
-
-
0013152329
-
Adjuvant immunotherapy for primary and early secondary malignant melanoma
-
Jose DG. Adjuvant immunotherapy for primary and early secondary malignant melanoma. Melanoma Res 1995; 5(S1):28
-
(1995)
Melanoma Res
, vol.5
, Issue.S1
, pp. 28
-
-
Jose, D.G.1
-
9
-
-
0021083089
-
Method for analysis of cellular DNA content of paraffin embedded pathological material using flow cytometry
-
Hedley DW, Freidlander ML, Taylor IW, et al. Method for analysis of cellular DNA content of paraffin embedded pathological material using flow cytometry. J Histochem Cytochem 1983;31:1333-1335
-
(1983)
J Histochem Cytochem
, vol.31
, pp. 1333-1335
-
-
Hedley, D.W.1
Freidlander, M.L.2
Taylor, I.W.3
-
10
-
-
33845382806
-
Nonparametric estimation of incomplete observations
-
Kaplan EL, Meier P. Nonparametric estimation of incomplete observations. J Am Stat Assoc 1958;53:457-481
-
(1958)
J Am Stat Assoc
, vol.53
, pp. 457-481
-
-
Kaplan, E.L.1
Meier, P.2
-
11
-
-
0000336139
-
Regression model and life tables
-
Cox DR. Regression model and life tables. J R Stat Soc 1972;34:187-220
-
(1972)
J R Stat Soc
, vol.34
, pp. 187-220
-
-
Cox, D.R.1
-
12
-
-
0022464586
-
Oncogenic amplification in tumour cells
-
Alitalo K, Schwab M. Oncogenic amplification in tumour cells. Adv Cancer Res 1986;47:235-281
-
(1986)
Adv Cancer Res
, vol.47
, pp. 235-281
-
-
Alitalo, K.1
Schwab, M.2
-
13
-
-
0025441769
-
The role of myc oncogenes in growth and differentiation
-
Littlewood TD, Evan GI. The role of myc oncogenes in growth and differentiation. Adv Dental Res 1990;4: 69-79
-
(1990)
Adv Dental Res
, vol.4
, pp. 69-79
-
-
Littlewood, T.D.1
Evan, G.I.2
-
14
-
-
0023227831
-
A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1
-
Heikkila R, Scwab G, Wickstrom E, et al. A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1. Nature 1987;328: 445-449
-
(1987)
Nature
, vol.328
, pp. 445-449
-
-
Heikkila, R.1
Scwab, G.2
Wickstrom, E.3
-
15
-
-
0023991151
-
c-myc down regulates class I HLA expression in human melanomas
-
Versteeg R, Noordermeer IA, Kruse-Walters M. c-myc down regulates class I HLA expression in human melanomas. EMBO J 1988;7:1023-1029
-
(1988)
EMBO J
, vol.7
, pp. 1023-1029
-
-
Versteeg, R.1
Noordermeer, I.A.2
Kruse-Walters, M.3
-
16
-
-
0027980103
-
Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes
-
Gaugler B, Van den Eynde B, Van der Bruggen P, et al. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J Exp Med 1994;179:921-930
-
(1994)
J Exp Med
, vol.179
, pp. 921-930
-
-
Gaugler, B.1
Van den Eynde, B.2
Van der Bruggen, P.3
|